1506P ctDNA testing based on deep NGS predicts treatment efficacy and prognosis in advanced pancreatic cancer patients
Pancreatic ductal adenocarcinoma (PDAC) is a rapidly progressing cancer with poor prognosis. This study explores the utility of deep next-generation sequencing (NGS) of ctDNA for managing locally advanced or metastatic PDAC.
Authors
- Chunmei Bai (ORCID: https://orcid.org/0000-0003-1333-9145)
- Y. Wang
- X. Wang
- Hui Tang (ORCID: https://orcid.org/0000-0001-8870-6726)
- Rongrong Chen (ORCID: https://orcid.org/0000-0002-4489-4179)
- Tao You (ORCID: https://orcid.org/0000-0003-2100-3318)
- M. Yuan (ORCID: https://orcid.org/0000-0002-0991-5026)
- Y. Cheng (ORCID: https://orcid.org/0009-0002-0483-913X)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Annals of Oncology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1016/j.annonc.2024.08.1569
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00